Book contents
- Frontmatter
- Contents
- Preface
- 1 Introduction
- 2 The normal bone marrow and an approach to bone marrow evaluation of neoplastic and proliferative processes
- 3 Granulomatous and histiocytic disorders
- 4 The aplasias
- 5 The hyperplasias
- 6 Other non-neoplastic marrow changes
- 7 Myelodysplastic syndromes
- 8 Acute leukemia
- 9 Chronic myeloproliferative disorders and systemic mastocytosis
- 10 Myelodysplastic/myeloproliferative disorders
- 11 Chronic lymphoproliferative disorders and malignant lymphoma
- 12 Immunosecretory disorders/plasma cell disorders and lymphoplasmacytic lymphoma
- 13 Metastatic lesions
- 14 Post-therapy bone marrow changes
- Index
- References
4 - The aplasias
Published online by Cambridge University Press: 07 August 2009
- Frontmatter
- Contents
- Preface
- 1 Introduction
- 2 The normal bone marrow and an approach to bone marrow evaluation of neoplastic and proliferative processes
- 3 Granulomatous and histiocytic disorders
- 4 The aplasias
- 5 The hyperplasias
- 6 Other non-neoplastic marrow changes
- 7 Myelodysplastic syndromes
- 8 Acute leukemia
- 9 Chronic myeloproliferative disorders and systemic mastocytosis
- 10 Myelodysplastic/myeloproliferative disorders
- 11 Chronic lymphoproliferative disorders and malignant lymphoma
- 12 Immunosecretory disorders/plasma cell disorders and lymphoplasmacytic lymphoma
- 13 Metastatic lesions
- 14 Post-therapy bone marrow changes
- Index
- References
Summary
Introduction
A decrease in bone marrow cellularity for a patient's age may be related to a variety of causes. Artifactual hypocellularity due to sampling of only subcortical marrow should not be misinterpreted, and an accurate estimate of marrow cellularity cannot be made on small biopsy specimens that contain only the subcortical marrow space. True hypocellularity may be due to a decrease in all marrow cell lines or decreases in only selected cell lines.
Aplastic anemia
Aplastic anemia (AA) may be acquired or constitutional (congenital), and represents a decrease in granulocytic, erythroid, and megakaryocytic cells (Guinan, 1997; Young, 1999). The principal conditions associated with the development of acquired and inherited aplastic anemia are summarized in Table 4.1.
Diagnostic criteria for severe aplastic anemia are (1) a bone marrow of less than 25% of normal age-related cellularity values, and (2) two of the following three peripheral blood findings: a neutrophil count of less than 0.5 × 109/L, a platelet count of less than 20 × 109/L, anemia with a corrected reticulocyte count of less than 1%. A grading system for AA patients is summarized in Table 4.2.
The peripheral blood demonstrates pancytopenia without obvious abnormalities of the circulating cells (Camitta et al., 1979). Aspirate smears usually show small particles containing histiocytes, mast cells, lymphocytes, and plasma cells with no or rare normal hematopoietic cells. The biopsy specimens in these patients are variably hypocellular (Fig. 4.1).
- Type
- Chapter
- Information
- Illustrated Pathology of the Bone Marrow , pp. 22 - 30Publisher: Cambridge University PressPrint publication year: 2006